Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Jan 01, 2020 11:27am

122 Views

Post# 30508241

RE:My wish for 2020--

Hi Impalaman that is too easy to occur .. the confidence level of Theralase is very high for success at all levels I.e. patient CR, IND approval and initiation of 2nd indication

Impalaman Wished

We hit 3.00 + and a nasdaq listing all before end of 2020-----we need US patients and a 90 day CR--to get our 20-35 patient fast track approval.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario